GSEA analysis showed that the high-risk group was significantly enriched in pathways for tumor progression, such as the JAK-STAT signaling pathway (36), cancer in pathway, TGF-β signaling pathway (37, 38), and NOTCH signaling pathway (39), leading to poor prognosis. The gene discussed is TGFB1; the disease is neoplasm.